What is the Enovis Corporation stock price forecast?

Enovis Corporation is currently trading at $21.58. View real-time AI analysis on Alpha Lenz.

What is Enovis Corporation insider trading activity?

View the latest insider trading data for Enovis Corporation on Alpha Lenz.

What is Enovis Corporation's P/E ratio?

Enovis Corporation's P/E ratio is -1.0.

Enovis Corporation

NYSE · ENOV

$21.58+0.60(+2.86%)Pre-market

Ask about Enovis Corporation's future dividend policy...

Alpha Chat Insight

“Enovis Corporation trades at a P/E of -1.0 (undervalued) with modest ROE of -58.5%. 3Y revenue CAGR of 12.9% highlights clear growth momentum.”

Ask for details →

Company Overview

Enovis Corporation is a diversified healthcare equipment company focused on developing and supplying a broad range of innovative medical technology solutions. The primary function of the company is to enhance patient care and improve treatment outcomes across various medical specialties. Enovis is known for its advanced surgical solutions, rehabilitation devices, and other healthcare innovations that serve both healthcare providers and patients. The company's products cater to sectors such as orthopedics, pain management, and wound care, offering a significant impact on surgical efficiencies and patient recovery. By providing a comprehensive portfolio of medical solutions, Enovis plays a vital role in the healthcare industry, supporting the demands of hospitals, clinics, and healthcare professionals. In the financial market, Enovis Corporation holds significance as it merges cutting-edge technology with healthcare services, contributing to the advancement of medical science and the betterment of patient-centric care. Its commitment to research and development underscores its role in shaping the future of healthcare, offering both therapeutic benefits and operational efficiencies.

CEOMr. Damien McDonald

Websitehttps://www.enovis.com

SectorHealthcare

IndustryMedical Devices

Employees7,367

Company Statistics

FY 2025

Profile

$1.23BMarket Cap

$2.25BRevenue

0.00Shares Out

7,367Employees

Margins

59.84%Gross

12.24%EBITDA

-0.84%Operating

-51.57%Pre-Tax

-52.65%Net

Valuation

-1.04P/E

0.83P/B

0.55EV/Sales

9.37EV/EBITDA

61.83P/FCF

Growth (CAGR)

12.88%Rev 3Yr

14.94%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-27.68%ROA

-58.46%ROE

-26.30%ROIC

Financial Health

$36.39MCash & Cash Equivalents

$2.31BNet Debt

157.04%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Enovis Corporation trades at a P/E of -1.0 (undervalued) with modest ROE of -58.5%. 3Y revenue CAGR of 12.9% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Enovis Corporation (ticker: ENOV) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 7,367 employees. Market cap is $1.2B.

The current price is $21.58 with a P/E ratio of -1.04x and P/B of 0.83x.

ROE is -58.46% and operating margin is -0.84%. Annual revenue is $2.2B.